Sigma Genetics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
15
Sigma Genetics General Information
Description
Developer of a nanosecond pulsed electric field (nsPEF) technology designed to deliver molecules into cells. The company's technology leverages precise electric field pulses and advances the manufacturing of life-saving therapies and cellular products, enabling biopharmaceutical companies to enhance molecular delivery while improving the efficiency and scalability of therapeutic production.
Contact Information
Website
www.sigmagenetics.comCorporate Office
- 1551 Eastlake Avenue East
- Suite Number 100
- Seattle, WA 98102
- United States
Corporate Office
- 1551 Eastlake Avenue East
- Suite Number 100
- Seattle, WA 98102
- United States
Sigma Genetics Timeline
Sigma Genetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 23-Mar-2026 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 27-Jan-2022 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue |
Sigma Genetics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sigma Genetics Patents
Sigma Genetics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025245377-A1 | Systems, devices, and methods for generating magnetoporation for delivery of extracellular material into cells | Pending | 23-May-2024 | ||
| EP-3559228-A1 | Systems, devices, and methods for elecroporation induced by magnetic fields | Pending | 09-Nov-2016 | ||
| EP-3559228-A4 | Systems, devices, and methods for elecroporation induced by magnetic fields | Pending | 09-Nov-2016 | ||
| WO-2018089690-A1 | Systems, devices, and methods for elecroporation induced by magnetic fields | Inactive | 09-Nov-2016 | ||
| AU-2017357919-A1 | Systems, devices, and methods for electroporation induced by magnetic fields | Active | 09-Nov-2016 | C12N13/00 |
Sigma Genetics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sigma Genetics Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | |||
| Capital Factory | Accelerator/Incubator | Minority | ||
| Andy Hill Care Fund | Government | |||
| Asymmetry Ventures | Venture Capital | Minority | ||
| Biosphere Investment Group | Venture Capital | Minority |
Sigma Genetics FAQs
-
When was Sigma Genetics founded?
Sigma Genetics was founded in 2016.
-
Where is Sigma Genetics headquartered?
Sigma Genetics is headquartered in Seattle, WA.
-
What is the size of Sigma Genetics?
Sigma Genetics has 10 total employees.
-
What industry is Sigma Genetics in?
Sigma Genetics’s primary industry is Drug Delivery.
-
Is Sigma Genetics a private or public company?
Sigma Genetics is a Private company.
-
What is Sigma Genetics’s current revenue?
The current revenue for Sigma Genetics is .
-
Who are Sigma Genetics’s investors?
Plug and Play, Capital Factory, Andy Hill Care Fund, Asymmetry Ventures, and Biosphere Investment Group are 5 of 15 investors who have invested in Sigma Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
